We are pleased to invite you to our satellite symposium, Targeting the Right Chemotherapy to the Right Patient: Optimizing Outcomes in Breast Cancer, an Official 2011 European Multidisciplinary Cancer Congress sponsored Satellite Symposium. This symposium will cover emerging data and provide updates on chemotherapy that are relevant to clinicians who provide care to patients with breast cancer. The activity will address educational needs pertaining to chemotherapy use and the application of recent data to challenging clinical scenarios, and will feature plenary lectures, faculty discussion, and case-based presentations with leading experts in the field of breast cancer.

Friday, 23 September 2011

14.00-16.00

Stockholmsmässan

Hall T1

Stockholm, Sweden 

This educational activity is specifically designed for medical oncologists, surgical and radiation oncologists, and other healthcare providers interested and/or involved in the treatment of patients with breast cancer.

After successful completion of this educational activity, participants should be able to:

• Discuss strategies to individualize chemotherapy for patients with breast cancer, including utilization of molecular profiling, biomarkers, and patient and disease characteristics

• Evaluate current standards of care for the use of chemotherapy in patients with breast cancer, and evaluate recent data regarding optimization of available therapies

• Examine the latest clinical trial data on novel chemotherapeutic agents and newer drug formulations and how these agents can be incorporated into current treatment regimens

• Identify appropriate treatment strategies for patients with heavily pretreated and/or refractory metastatic breast cancer

Co-Chairs

Luca Gianni, MD San Raffaele Institute Milan, Italy     Faculty Robert E. Coleman, MD, FRCP, FRCPE University of Sheffield Sheffield, United Kingdom   Christian Jackisch, MD, PhD Klinikum Offenbach Offenbach, Germany   Hope Rugo, MD University of California San Francisco San Francisco, California, United States

Carsten Rose, MD Lund University Hospital Lund, Sweden

	Welcome and introduction Luca Gianni, MD Carsten Rose, MD
14.00	Choosing the right chemotherapy: Where are we today? Carsten Rose, MD
14.10	Redefining the role of taxanes in breast cancer: How should clinicians incorporate new data? Hope Rugo, MD
14.30	Clinical scenario #1—Progressive metastatic breast cancer: A dilemma in search of practical solutions? Christian Jackisch, MD, PhD
14.55	Faculty discussion
15.00	Clinical scenario #2—Managing disease recurrence after adjuvant chemotherapy: How can we fine tune our approach? Robert E. Coleman, MD, FRCP, FRCPE
15.25	Faculty discussion
15.30	Clinical scenario #3—Optimizing therapeutic choices: How can clinicians use molecular phenotype to achieve this goal? Hope Rugo, MD
15.55	Symposium summary and concluding remarks Luca Gianni, MD Carsten Rose, MD